Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01B ANTIMALARIALS
P01BF Artemisinin and derivatives, combinations
P01BF01 Artemether and lumefantrine
D02484 Artemether and lumefantrine <JP/US>
USP drug classification [BR:br08302]
Antiparasitics
Antiprotozoals
Artemether/ Lumefantrine
D02484 Artemether and lumefantrine
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
64 Parasitics (systemic)
641 Antiprotozoans
6419 Others
D02484 Artemether and lumefantrine
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D02484 Artemether and lumefantrine
Antimicrobials [BR:br08307]
Antiparasitics
Antmalarials
Artemisinin and derivatives
D02484 Artemether and lumefantrine <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02484
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02484
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02484
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02484